Table 3 Risk factors in total population, in group with and without cardiac complications
Risk factor | Total population | Group with cardiac complications | Group with no cardiac complications | Value of p no complications vs complications | ||
|---|---|---|---|---|---|---|
|  | N = 100 | N = 38 | N = 62 |  | ||
Age (years) | 46 | 47 | 45 | 0.96 | ||
Overweight | 38% | 12 (31.57%) | 26 (41.93%) | 0.61 | ||
obesity | 35% | 16 (42.10%) | 19 (30.64%) | 0.57 | ||
Hypertension | 11% | 4 (10.52%) | 7 (11.29%) | 0.88 | ||
Diabetes | 7% | 3 (7.89%) | 4 (6.45%) | 0.31 | ||
LVFE baseline | 70% | 74% | 67% | < 0.001 | ||
Chemotherapy with or without anthracycline | 100% | Sequential | 25 (65.5%) | Sequential | 35 (56.5%) | 0.3 |
anthracycline | 13 (34.5%) | anthracycline | 27 (43.5%) | |||
Nb of anthracycline cycles | 4 | 4 | 4 | 0.61 | ||
Concomitant radiotherapy with trastuzumab | 69 | 24 (63%) | 45 (72%) | 0.318 | ||